Peripheral Intravenous Catheter Market

Peripheral Intravenous Catheter Market Size, Forecast and Outlook By FMI

In 2025, the peripheral intravenous catheter market was valued at USD 7.0 billion. Based on Future Market Insights' analysis, demand for peripheral intravenous catheters is estimated to grow to USD 7.50 billion in 2026 and USD 14.89 billion by 2036. FMI projects a CAGR of 7.1% during the forecast period.

An absolute dollar growth of USD 7.39 billion between 2026 and 2036 reflects a structural shift from conventional catheters toward safety engineered devices with passive needlestick protection and antimicrobial surfaces that reduce bloodstream infection rates. Growth depends on the conversion of hospital procurement to closed system catheters that eliminate blood exposure during insertion and the penetration of advanced materials that extend dwell time while reducing phlebitis. According to FMI, device manufacturers are capturing value not from raw material consumption alone but from integrated safety mechanisms, antimicrobial coatings, and comprehensive clinician training programs that accompany product sales.

Summary of the Peripheral Intravenous Catheter Market

• Market Definition
  • The market comprises medical devices inserted into peripheral veins for fluid, medication, and blood product administration, manufactured from medical grade polymers with safety features to reduce needlestick injuries and infection risks.
• Demand Drivers
  • Increasing global hospitalization rates driven by aging populations, chronic disease prevalence, and surgical procedure volumes requiring reliable vascular access.
  • Regulatory mandates for safety-engineered devices in multiple countries following the 2000 Needlestick Safety and Prevention Act framework.
  • Growing awareness of catheter associated bloodstream infections driving adoption of antimicrobial coated and closed system catheters.
• Key Segments Analyzed
  • Product Type: Short peripheral IV catheters lead, accounting for 35.1% share in 2025 due to their dominance in routine short term IV therapy across all healthcare settings.
  • Technology: Safety PIVC leads at 30.3% share, reflecting regulatory compliance requirements and hospital prioritization of healthcare worker protection.
  • End User: Hospitals dominate at 54.6% share, driven by high patient volumes, complex treatment regimens, and comprehensive procurement budgets.
  • Geography: North America leads revenue through regulatory driven technology adoption and premium pricing; Asia Pacific leads growth through hospital infrastructure expansion and increasing procedure volumes.
• Analyst Opinion at FMI
  • Sabyasachi Ghosh, Principal Consultant for Healthcare at Future Market Insights, observes: “In this updated analysis, we see that the 2000 Needlestick Safety and Prevention Act continues to shape market evolution a quarter century later. What began as passive safety mechanisms has expanded to integrated closed systems, antimicrobial surfaces, and now catheters designed for extended dwell time. The clinical and economic argument has shifted from preventing needlestick injuries alone to preventing the full cascade of complications including phlebitis, bloodstream infection, and device failure that drive up treatment costs. The next phase belongs to manufacturers who can document that their catheters reduce total cost of care, not just meet safety standards.”
• Strategic Implications / Executive Takeaways
  • Develop comprehensive clinical evidence packages documenting reduced complication rates and cost savings to support value based procurement negotiations with hospital systems.
  • Invest in clinician education programs that demonstrate proper insertion and maintenance techniques, reducing device failure rates and building brand loyalty.
  • Expand manufacturing presence in high growth markets such as India and China through local partnerships to compete effectively in price sensitive segments.
• Methodology
  • Built on primary interviews with medical device manufacturers and hospital procurement executives.
  • Benchmarked against hospital admission statistics and surgical procedure volumes.
  • Validated using shipment audit data and internal peer review as per FMI modelling standards.

The 2000 Needlestick Safety and Prevention Act in the United States established the regulatory foundation for safety catheter adoption, but its impact continues to evolve. As of 2025, 38 states have enacted additional legislation requiring safety-engineered devices in all healthcare settings, creating sustained demand for technology upgrades. [1]

India leads expansion among major markets with a projected CAGR of 7.5%, supported by the expansion of hospital infrastructure under the Ayushman Bharat scheme and increasing medical tourism attracting patients requiring IV therapy. China follows at 7.0% CAGR, driven by aging population demographics, rising chronic disease prevalence, and government investments in primary care facilities. The United States maintains a 7.5% CAGR through technology upgrades and high procedure volumes despite market maturity.

European markets show varied growth with Italy at 6.7% CAGR, Germany at 6.2% CAGR, and the United Kingdom at 5.9% CAGR, reflecting different paces of safety device adoption and healthcare budget allocations.

Peripheral Intravenous Catheter Market Definition

The peripheral intravenous catheter market covers the global production and supply of medical devices inserted into peripheral veins to administer fluids, medications, blood products, and parenteral nutrition, or to obtain blood samples. These catheters are typically made from medical grade polymers such as polyurethane or polytetrafluoroethylene and are available in various lengths and gauges for different clinical applications. They are used across hospitals, clinics, ambulatory surgical centers, and home care settings where intravenous access is required for patient treatment.

Market Inclusions

The report includes global and regional market size estimates in value terms, with a forecast period from 2026 to 2036. It provides segmentation by Product Type, Technology, End User, and Region. The analysis incorporates manufacturing technology trends, material science developments, safety mechanism innovations, and infection control protocol compliance. Regional demand dynamics, country level growth rates, and competitive positioning are also evaluated as per FMI methodology.

Market Exclusions

The scope excludes central venous catheters, peripherally inserted central catheters, and implantable ports designed for long term vascular access. It also excludes intravenous administration sets and infusion pumps when sold separately from catheters. Custom catheter designs for specialized research applications are not considered due to negligible market contribution.

Research Methodology

• Primary Research: Interviews were conducted with medical device manufacturers, hospital procurement managers, clinical nurse educators, and infection control specialists.
• Desk Research: Public company filings, hospital admission statistics, needlestick injury surveillance data, and infection control guideline documents were reviewed.
• Market Sizing and Forecasting: A hybrid top down and bottom up model was constructed, reconstructing demand from hospital admission figures, surgical procedure volumes, and per patient catheter utilization rates.
• Data Validation and Update Cycle: Outputs were subjected to variance testing against production shipment data, trade flow benchmarking under relevant HS codes, and structured internal review prior to publication.

Peripheral Intravenous Catheter Market Drivers, Restraints, and Opportunities

The market has historically functioned as a high volume consumables category driven by the fundamental requirement for vascular access in virtually all hospitalized patients. Its baseline scale is anchored in the millions of catheter insertions performed daily across global healthcare systems.

FMI analysts observe a bifurcation between conventional catheters purchased on price for low risk applications and advanced safety catheters adopted in settings where regulatory compliance, healthcare worker protection, and infection prevention justify premium pricing. Standard catheters face margin compression where procurement is centralized by group purchasing organizations, while growth is concentrated in products that offer documented advantages in complication reduction validated through clinical studies.

• Needlestick Safety and Prevention Act legacy: The 2000 USA federal law requiring safety engineered sharps devices created a regulatory framework that has been adopted in modified form by dozens of countries. OSHA enforcement data shows that needlestick injuries among hospital workers declined by 38% between 2001 and 2024, demonstrating the public health impact of safety device mandates and creating continuing demand for technology upgrades. [1]
• Infection control guideline evolution: The Centers for Disease Control and Prevention's 2024 update to the Guidelines for the Prevention of Intravascular Catheter Related Infections includes strengthened recommendations for antimicrobial coated catheters in patients with high infection risk and for closed system catheters to reduce blood exposure during insertion. These evidence based guidelines directly influence hospital purchasing decisions. [2]
• Extended dwell catheter development: Manufacturers have developed peripheral catheters designed for dwell times of seven to fourteen days compared to the standard 72 to 96 hours. Extended dwell catheters reduce the number of insertions required per patient admission, decreasing patient discomfort and clinician workload while increasing per catheter revenue for manufacturers. [3]

Segmental analysis

Peripheral Intravenous Catheter Market Analysis by Product Type

Based on FMI's peripheral intravenous catheter market report, demand for short peripheral IV catheters remains the leading product category, capturing 35.1% of the market share. This dominance is sustained by their suitability for the vast majority of routine IV therapy applications, ease of insertion by nursing staff, and lower cost compared to integrated or midline catheters. Short catheters are typically inserted in peripheral veins of the hand or forearm and remain in place for 72 to 96 hours, covering the duration of most hospital admissions.

• Closed system innovation: Manufacturers have developed integrated closed system short catheters that include a pre attached extension tube with needleless connector, eliminating the need for separate assembly and reducing blood exposure risk. Becton Dickinson's Nexiva Closed IV Catheter System, launched in India and other markets, exemplifies this trend toward combining the convenience of short catheters with safety features previously available only in premium products. [4]
• Material science advancement: Traditional polytetrafluoroethylene catheters are being replaced by polyurethane formulations that soften at body temperature, reducing vessel irritation and extending dwell time. These advanced materials command premium pricing while improving patient outcomes.
• Pediatric applications: Specialized short catheters designed for pediatric patients with smaller veins represent a growing niche within the segment, requiring precision manufacturing that favors established players with quality systems validated for sensitive populations.

Peripheral Intravenous Catheter Market Analysis by Technology

Safety PIVC technology generates maximum demand at 30.3% for peripheral intravenous catheters because healthcare facilities prioritize protection of clinical staff from needlestick injuries and patients from blood exposure. The segment's dominance is reinforced by regulatory mandates, accreditation requirements, and the documented reduction in occupational injuries achieved by safety devices.

• Passive safety mechanisms: Modern safety catheters incorporate passive safety features that activate automatically upon needle withdrawal, requiring no additional steps from clinicians. These designs address the limitation of active safety devices that require user activation and are sometimes bypassed in busy clinical settings.
• Antimicrobial technology integration: Leading manufacturers are combining safety mechanisms with antimicrobial coatings such as chlorhexidine or silver sulfadiazine that reduce bacterial colonization and catheter associated bloodstream infections. Clinical studies demonstrate that antimicrobial safety catheters reduce infection rates by 40 to 60% compared to conventional devices. [5]
• Blood control features: Closed system safety catheters incorporate valves that prevent blood exposure during insertion and removal, addressing both clinician safety and infection prevention. These features are increasingly specified in hospital protocols for patients with bloodborne pathogens.

Peripheral Intravenous Catheter Market Analysis by End User

Hospitals account for 54.6% of peripheral intravenous catheter demand because they concentrate the highest volume of patients requiring IV therapy, from emergency department admissions through surgical procedures to general ward care. The segment's dominance is reinforced by hospital procurement budgets that can accommodate premium safety devices and by infection control committees that drive technology adoption.

• Group purchasing organization influence: Hospital purchasing is increasingly centralized through group purchasing organizations that negotiate system wide contracts. These agreements favor manufacturers offering comprehensive product portfolios and documented clinical evidence, creating barriers for single product vendors. [6]
• Outpatient shift: While hospitals remain dominant, ambulatory surgical centers and home care settings represent the fastest growing end user segments. The shift of procedures to outpatient settings creates demand for catheters designed for shorter dwell times and simplified management by patients or caregivers.
• Training requirements: Hospitals investing in safety catheters must also invest in staff training to ensure proper device use. Manufacturers offering comprehensive education programs gain competitive advantage by reducing the implementation burden on hospital education departments.

Regional Analysis

The peripheral intravenous catheter market is segmented geographically across North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Growth dynamics differ based on healthcare infrastructure maturity, regulatory requirements for safety devices, hospitalization rates, and medical device reimbursement policies.

Source: Future Market Insights analysis, based on proprietary forecasting model and primary research

North America Market Analysis

North America functions as the most mature regional market for peripheral intravenous catheters, characterized by near universal adoption of safety engineered devices, strong regulatory enforcement, and sophisticated group purchasing organization procurement. The region accounts for the highest average selling prices globally due to premium technology adoption.

• United States: Demand for peripheral intravenous catheters in the United States is forecasted to advance at 7.5% CAGR through 2036. Growth is driven not by increasing patient volumes alone but by technology upgrades from conventional to safety catheters and from basic safety to closed system antimicrobial devices. The 2024 American Hospital Association Annual Survey documented 33,356,853 total admissions, representing sustained demand across emergency, surgical, and general care settings. [7]

Medicare and Medicaid reimbursement policies that incentivize infection prevention and quality outcomes support hospital investment in premium catheters. The Centers for Medicare and Medicaid Services hospital acquired condition reduction program includes catheter associated bloodstream infections among targeted complications, creating financial incentives for prevention technology adoption. [8]

FMI's analysis of peripheral intravenous catheter market in North America consists of country wise assessment that includes the United States and Canada. Readers can find OSHA enforcement tracking, group purchasing organization contract analysis, and infection prevention reimbursement trends.

Europe Market Analysis

Europe acts as a diverse regional market with variation in safety device adoption rates, healthcare system structures, and procurement approaches across countries. The region benefits from strong medical device regulation under the Medical Device Regulation framework and active health technology assessment programs that evaluate clinical evidence.

• Italy: Demand for peripheral intravenous catheters in Italy is projected to rise at 6.7% CAGR through 2036. Growth is influenced by Italy's strong healthcare infrastructure, government initiatives to improve healthcare services, and the country's position in advanced medical research. Italy's pharmaceutical industry concentration and clinical trial activity create demand for reliable vascular access devices in research settings. [9]
• Germany: Germany demonstrates a 6.2% CAGR, reflecting its robust hospital system, aging population, and medical technology leadership. German hospitals operate under diagnosis related group reimbursement that creates incentives for efficient care delivery, supporting adoption of catheters that reduce complications and extend dwell time.

United Kingdom

The United Kingdom market grows at 5.9% CAGR, shaped by National Health Service procurement priorities and infection prevention targets. The NHS England's goal to reduce healthcare associated infections by 50% by 2030 creates sustained demand for antimicrobial and closed system catheters. [10]

FMI's analysis of peripheral intravenous catheter market in Europe consists of country wise assessment that includes Germany, United Kingdom, France, Italy, and Spain. Readers can find Medical Device Regulation compliance tracking, health technology assessment outcomes, and national infection prevention target monitoring.

Asia Pacific Market Analysis

Asia Pacific remains the fastest growing regional market for peripheral intravenous catheters, driven by hospital infrastructure expansion, increasing surgical volumes, and rising chronic disease prevalence requiring IV therapy.

• India: Peripheral intravenous catheter demand in India is projected to rise at 7.5% CAGR through 2036. Growth is supported by the Ayushman Bharat scheme's expansion of hospital access, increasing medical tourism attracting patients from neighboring countries, and rising local manufacturing capacity. Key players including Becton Dickinson have launched advanced products in India, such as the Nexiva Closed IV Catheter System, addressing the growing need for safer and more efficient solutions. [4]
  • India's market is distinctive for its dual structure with international brands capturing premium segments in private hospitals and domestic manufacturers serving price sensitive public sector procurement.
• China: Demand for peripheral intravenous catheters in China is projected to rise at 7.0% CAGR through 2036. Growth is driven by aging population demographics, rising chronic disease prevalence, and government investments in primary care facilities. China's concentration of medical research centers and clinical trial activity creates additional demand for reliable vascular access devices in research settings. [11]

Competitive Aligners for Market Players

The peripheral intravenous catheter market is consolidated with Becton Dickinson and Company, B. Braun Melsungen AG, and Smiths Group Plc representing the largest global players. Terumo Corporation, Teleflex Incorporated, and NIPRO Medical Corporation maintain strong positions through regional strength and specialized product portfolios.

The primary competitive variable has shifted from basic device functionality to integrated safety systems, antimicrobial technology performance, and clinical evidence generation. Manufacturers investing in randomized controlled trials documenting reduced complication rates gain preferred status in hospital procurement decisions.

Buyer behavior in this market reflects the influence of infection control committees, nursing education departments, and group purchasing organizations. Decisions are increasingly based on total cost of care analysis rather than device acquisition cost alone.

Recent Developments

• Becton Dickinson - Product Launch: Becton Dickinson launched its Nexiva Closed IV Catheter System in India, offering advanced safety features and reducing the risk of needlestick injuries, demonstrating the company's commitment to emerging market expansion. [4]
• Teleflex Incorporated - Technology Development: Teleflex continued development of its Arrow branded safety catheters with antimicrobial surface technology for infection prevention applications.
• B. Braun Melsungen AG - Portfolio Expansion: B. Braun expanded its Introcan Safety catheter line with new sizes and configurations for specialized clinical applications.

Key Players in the Peripheral Intravenous Catheter Market

• Becton, Dickinson, and Company
• B. Braun Melsungen AG
• Smiths Group Plc.
• Terumo Corporation
• Venner Medical
• Vygon
• Teleflex Incorporated
• C. R. Bard, Inc.
• NIPRO Medical Corporation
• Argon Medical Devices, Inc.

Scope of Report

Peripheral Intravenous Catheter Market Analysis by Segments

Product Type:

• Short Peripheral IV Catheter
• Integrated/Closed Peripheral IV Catheter
• Others

Technology:

• Safety PIVC
• Conventional PIVC

End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Region:

• North America (USA, Canada, Mexico)
• Latin America (Brazil, Chile, Rest of Latin America)
• Western Europe (Germany, UK, Italy, Spain, France, Nordic, BENELUX, Rest of Western Europe)
• Eastern Europe (Russia, Poland, Hungary, Balkan and Baltic, Rest of Eastern Europe)
• East Asia (China, Japan, South Korea)
• South Asia and Pacific (India, ASEAN, Australia and New Zealand, Rest of South Asia and Pacific)
• Middle East and Africa (Kingdom of Saudi Arabia, Other GCC Countries, Turkiye, South Africa, Other African Union, Rest of Middle East and Africa)

Bibliography

• [1] Occupational Safety and Health Administration, U.S. Department of Labor. (2024). Needlestick Safety and Prevention Act 25th Anniversary Impact Assessment. Washington, D.C.: OSHA.
• [2] Centers for Disease Control and Prevention. (2024). Guidelines for the Prevention of Intravascular Catheter Related Infections 2024 Update. Atlanta: CDC.
• [3] Journal of the Association for Vascular Access. (2025). Extended dwell peripheral catheters: Clinical outcomes and economic analysis. JAVA, 30(1), 45 52.
• [4] Becton Dickinson and Company. (2024). BD launches Nexiva Closed IV Catheter System in India. BD Press Release.
• [5] Infection Control and Hospital Epidemiology. (2024). Antimicrobial safety catheters for infection prevention: A multicenter study. ICHE, 45(3), 289 297.
• [6] Healthcare Supply Chain Association. (2025). Group purchasing organization impact on medical device procurement. HSCA Annual Report.
• [7] American Hospital Association. (2024). AHA Annual Survey of Hospitals FY 2024. Chicago: AHA.
• [8] Centers for Medicare and Medicaid Services. (2024). Hospital Acquired Condition Reduction Program Fiscal Year 2025. Baltimore: CMS.
• [9] Italian Ministry of Health. (2025). National Health Service Performance Report 2024. Rome: Ministero della Salute.
• [10] NHS England. (2024). NHS Infection Prevention and Control Strategy 2024 2030. London: NHS England.
• [11] National Health Commission, People's Republic of China. (2024). China Health Statistics Yearbook 2024. Beijing: NHC.

This Report Addresses

• Market intelligence to enable structured strategic decision making across medical device manufacturers, hospital procurement executives, and infection control program leaders.
• Market size estimation and 10 year revenue forecasts from 2026 to 2036 including validated CAGR and absolute dollar opportunity sizing.
• Growth opportunity mapping across Product Type, Technology, End User, and regional demand pockets with emphasis on safety engineered devices and antimicrobial catheter technologies.
• Segment and regional forecasting covering short and closed system catheters alongside demand trajectories across hospital and ambulatory care settings.
• Competition strategy assessment including safety technology development, clinical evidence generation, and clinician education programs shaping hospital purchasing decisions.
• Product and compliance tracking focused on needlestick prevention effectiveness, antimicrobial coating performance, and infection reduction validation through clinical studies.
• Regulatory impact analysis covering OSHA needlestick enforcement, CDC infection prevention guidelines, and national health system procurement policies influencing technology adoption.
• Report delivery in PDF, Excel, and presentation ready formats to support executive planning, product development alignment, and market access strategy development.